# John L. Perez

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-l-perez/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,041 |
| Field | Bacterial Infections and Vaccines |
| h-index | 36 |
| i10-index | 56 |
| Last Known Institution | AstraZeneca (France) |
| OpenAlex ID | https://openalex.org/A5025483944 |
| Works | 98 |

## Researcher papers

- [The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment](https://scholariq.org/papers/the-premier-study-a-multicenter-randomized-double-blind-clinical-trial-of/)

## Researcher topics

- [Bacterial Infections and Vaccines](https://scholariq.org/topics/bacterial-infections-and-vaccines/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Virology and Viral Diseases](https://scholariq.org/topics/virology-and-viral-diseases-2/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches-2/)

## Researcher university

- [AstraZeneca (France)](https://scholariq.org/institutions/astrazeneca-france/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.